• Latest Posts

Eight diseases CRISPR technology could cure

Roche and Alnylam to work on RNAi therapeutic to treat hypertension

von Willebrand disease treatment gets FDA orphan drug designation

How thalassemia gene therapy approval is making a difference

In Depth 18 Apr 2023

Gene therapy: a powerful tool for hemophilia B?

Novartis delivers German Biotech’s 12th Antibody to Clinics

ADVERTISEMENT

Best-in-Class Label for Blood Cancer Trial by Billion Euro Biotech

Series A Boost for Swedish Biotech’s Sickle Cell Disease Treatment

New Discovery unites Australia, Germany and UK Against Blood Cancers

Berlin Biotech Breakthrough: Myelo is Only 3 Years old and Already Starting a Phase II Trial for Breast Cancer!

Hemab Therapeutics receives $135M to address bleeding and thrombotic disorders

Disc Medicine raises $62.5M for hematology programs

ADVERTISEMENT